scispace - formally typeset
P

Peter M. Lauer

Researcher at University of California

Publications -  34
Citations -  1614

Peter M. Lauer is an academic researcher from University of California. The author has contributed to research in topics: Fusion protein & Multiple cloning site. The author has an hindex of 14, co-authored 34 publications receiving 1556 citations. Previous affiliations of Peter M. Lauer include University of California, Berkeley & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

Construction, Characterization, and Use of Two Listeria monocytogenes Site-Specific Phage Integration Vectors

TL;DR: Two site-specific shuttle integration vectors were developed with two different chromosomal bacteriophage integration sites to facilitate strain construction in Listeria monocytogenes and integrated pPL1-complemented strains were fully virulent in the mouse 50% lethal dose assay.
Journal ArticleDOI

Complete nucleotide sequence, molecular analysis and genome structure of bacteriophage A118 of Listeria monocytogenes : implications for phage evolution

TL;DR: Comparative analysis of the A118 genome structure with other bacteriophages revealed local, but sometimes extensive, similarities to a number of phages spanning a broader phylogenetic range of various low G+C host bacteria, which implies relatively recent exchange of genes or genetic modules.
Journal ArticleDOI

Identification of flagellar synthesis regulatory and structural genes in a sigma D-dependent operon of Bacillus subtilis.

TL;DR: An operon of genes transcribed from the sigma D-dependent promoter PD-1 is described, which encodes the presumptive B. subtilis homologs of two Salmonella typhimurium late flagellar genes, flgM and flgK.
Journal ArticleDOI

Constitutive Activation of the PrfA Regulon Enhances the Potency of Vaccines Based on Live-Attenuated and Killed but Metabolically Active Listeria monocytogenes Strains

TL;DR: It is shown that PrfA*(G155S) enhanced functional cellular immunity following an intravenous or intramuscular prime-boost immunization regimen, form the basis of a rationale for including the prfA(G 155S) allele in future live-attenuated or KBMA L. monocytogenes vaccines advanced to the clinical setting.